SSH (Hangzhou) Pharmaceutical Co., Ltd.

   SSH（Hangzhou） Pharmaceutical Co., Ltd, established in March 2020 and located in the core area of Hangzhou Pharmaceutical Port, is a full-industry chain pharmaceutical technology enterprise specializing in the research, development, production, and commercialization of high-end generic drugs, improved new drugs, and innovative drugs. The company adheres to the mission of "Let life and health go hand in hand", with "Speedy, Safety, Healthy" as its core values, and is driven by the dual development strategy of "first generic + innovation", committed to providing high-quality and reliable treatment options and health services for patients worldwide.    The company was founded under the leadership of Dr. Liao Jianwei, with a core team consisting of 15-20 years of experienced professionals in the pharmaceutical industry, possessing full-chain practical capabilities. Since its establishment, it has quickly achieved the approval and launch of two first generic drugs, with core products included in national medical insurance, obtained dozens of invention patents, and was awarded as a specialized, refined, unique, and innovative small and medium-sized enterprise in Zhejiang Province.     SSH Pharmaceutical, with the vision of "becoming a globally leading pharmaceutical enterprise in the field of specialized treatment," adheres to the core strategy of "research and development as the foundation, quality as the core, patient-centered, and innovation-driven development." It continuously delves into advantageous fields such as anti-infection, kidney disease, reproductive health, and surgical medication, accelerates the research and development transformation of innovative drugs and high-end generic drugs, continuously improves drug accessibility and clinical value, supports the implementation of the Healthy China 2030 strategy, and contributes professional strength to the cause of human health.